Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control (Nature Communications, (2019), 10, 1, (3874), 10.1038/s41467-019-11782-w)

Zhichen Sun; Zhenhua Ren; Kaiting Yang; Zhida Liu; Shuaishuai Cao; Sisi Deng; Lily Xu; Yong Liang; Jingya Guo; Yingjie Bian; Hairong Xu; Jiyun Shi; Fan Wang; Yang Xin Fu; Hua Peng

ArticleOPEN ACCESS

Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control (Nature Communications, (2019), 10, 1, (3874), 10.1038/s41467-019-11782-w)

Sun Z
Ren Z
Yang K
et al.

Nature Communications

DOI: 10.1038/s41467-020-15532-1

3Citations

26Readers

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite

CITATION STYLE

APA

Sun, Z., Ren, Z., Yang, K., Liu, Z., Cao, S., Deng, S., … Peng, H. (2020, December 1). Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control (Nature Communications, (2019), 10, 1, (3874), 10.1038/s41467-019-11782-w). Nature Communications. Nature Research. https://doi.org/10.1038/s41467-020-15532-1

Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control (Nature Communications, (2019), 10, 1, (3874), 10.1038/s41467-019-11782-w)

Abstract

Cite

Register to see more suggestions